Net Interest Margin

Despite a historic tariff shock, new data shows middle market dealmaking adapted and thrived, with private equity rewriting its playbook for a new era.

As Sri Lanka emerges from its economic crisis, a first-of-its-kind European-regulated fund provides a liquid, secure path to its undervalued assets.

Following a strategic balance sheet overhaul and strong earnings, the regional bank's new repurchase program sends a bullish message to investors.

After a year of major acquisitions and divestitures, the packaging giant posts surging profits and outlines a simplified, focused strategy for 2026.

Top policymakers, including Dr. Agustín Carstens and FATF President Luis Urrutia Corral, will convene in Mérida to address critical cross-border tax issues.

Chinese data center giant VNET promotes Peter Zhang to SVP, signaling a focus on stability and governance as it navigates rapid AI-driven growth.

Anebulo Pharmaceuticals is delisting from Nasdaq to focus on a pediatric cannabis antidote, leaving investors to grapple with an uncertain future.

As Liberty Latin America preps its 2025 results, investors watch to see if strong subscriber growth and cost-cutting can sustain momentum in a competitive market.

After a major trial failure tanked its stock, Rezolute pins its hopes on a second drug program and a crucial FDA meeting to chart a path forward.

As AI pushes data centers to their limits, the optical industry gathers at OFC 2026 to unveil the power-efficient, high-speed networks of the future.

Lincoln International data reveals slowing growth and rising debt distress in private companies, a stark contrast to the heated M&A market for top assets.

A massive $313M federal funding win brings hope to the ALS community, pushing total investment past $1.6B. But how close are we to a real breakthrough?

For the seventh year, General Mills is one of America's most responsible companies. We explore the data, public trust, and strategy behind this major ESG achievement.

Exodus reports a surge in users and swap volume for January, defying a market downturn while strategically increasing its Solana treasury holdings.

The digital bank posted 45% net income growth and a 36% credit surge, proving rapid expansion and profitability can coexist in Latin America's fintech wars.

A new deal for the rare isotope Actinium-225 could break a major supply bottleneck, accelerating the development of highly targeted cancer treatments.

With its foundational drug a success, Madrigal bets billions on next-gen siRNA tech, aiming to fuse it with Rezdiffra and dominate MASH treatment.

A new report shows the carbon removal market has the tools to fight climate change, but widespread corporate inaction threatens to strand vital projects.

Fresh off a strategic rebrand and a record-breaking year, Potomac Bancshares is courting investors and cementing its role as a Mid-Atlantic banking leader.

With its IPO complete, Cambridge Acquisition Corp. enters a disciplined SPAC market with a clear focus on wellness, hemp, and psychedelic tech targets.